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2-Deoxy-D*glucose preferentially kills multidrug-
resistant human KB carcinoma cell lines by apoptosis
SE Bell, DM Quinn, GL Kellett and JR Warr
Department of Biology, The University of York, PO Box 373, York YO10 5YW, UK
Summary The aim of this study was to determine the mechanism of cell death associated with the preferential killing of multidrug-resistant
(MDR) cells by the glycolytic inhibitor 2-deoxy-D-glucose (2DG) in a range of MDR human KB carcinoma cell lines selected in different drugs.
The D10 values for KB-Vl, KB-Cl and KB-Al (selected in vinblastine, colchicine and doxorubicin respectively) were 1.74, 1.04 and 0.31 mM,
respectively, compared with 4.60 mm for the parental cell line (KB-3-1). The mechanism of cell death was identified as apoptosis, based on
nuclear morphology, annexin V binding and poly(ADP-ribose) polymerase (PARP) cleavage. 2DG induced apoptosis in the three MDR cell
lines in a dose- and time-dependent manner and did not induce necrosis. PARP cleavage was detected in KB-Cl cells within 2 h of exposure
to 50 mM 2DG and slightly later in KB-Al and KB-Vl cells. The relative levels of 2DG sensitivity did not correlate with the levels of multidrug
resistance or with the reduced levels of the glucose transporter GLUT-1 in these cells. We speculate that a 2DG-stimulated apoptotic pathway
in MDR KB cells differs from that in normal KB cells.
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Multidrug resistance, involving cross-resistance to chemothera-
peutic drugs, is thought to be a significant obstacle in the
successful treatment of several haematological malignancies
(Filipits et al, 1996; Malayeri et al, 1996) and is likely to
contribute to resistance in certain solid tumours (Bellamy and
Dalton 1994; Shustik et al, 1995; Trock et al, 1997). It is
frequently mediated by overexpression of the P-glycoprotein
(Pgp), which functions as an ATP-dependent drug-efflux pump
(Gottesman and Pastan, 1993; Germann, 1996).
The development of multidrug resistance in cancer cells is
accompanied by other changes that are potentially exploitable for
their selective killing. It is often associated with an increased rate
ofglycolysis (Jain et al, 1985; Cohen and Lyon, 1987). Even in the
absence of increased glycolytic rates relative to parental cells,
glycolysis is the main energy-yielding pathway in multidrug-
resistant (MDR) cells (Lyon et al, 1988; Fanciulli et al, 1993;
Rasmussen et al, 1993). These observations suggest the possibility
of selective killing of MDR cells by glycolytic inhibitors, e.g. 2-
deoxy-D-glucose (2DG).
2DG is a glucose analogue that acts by competitively inhibiting
glucose uptake, mediated by the facilitative glucose transporter
GLUT-1. It inhibits glucose utilization via its metabolic product
2-deoxy-D-glucose-6-phosphate, which blocks phosphoglucose
isomerase and results in cellular ATP depletion (Wick et al, 1957).
2DG has been shown to be preferentially toxic to a range of
MDR cell lines, and there is a good correlation between the level
of multidrug resistance and 2DG sensitivity in cells selected with
the same agent (Kaplan et al, 1990, 1991; Bentley et al, 1996). In
the colchicine-selected series KB-8-5, KB-8-5-11 and KB-Cl, we
have shown that the development of multidrug resistance is
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accompanied by a decrease in the expression of GLUT-1, and
proposed that the increased energy demand and glucose depen-
dency in MDR cells, in combination with lower GLUT-I trans-
porter levels, renders MDR cells preferentially sensitive to the
antiglycolytic effects of 2DG (Bentley et al, 1996). However, in
cells selected with different cytotoxic agents, e.g. KB-Al and KB-
VI (selected in doxorubicin and vinblastine respectively), there is
no correlation between the level of multidrug resistance and 2DG
sensitivity (Kaplan et al, 1991). This suggests that drug selection
induces other changes, in addition to Pgp expression, that are
involved in determining the cellular response to 2DG exposure.
The preferential susceptibility of MDR cells to 2DG or to other
treatments implies that such cells have properties that may ulti-
mately beexploited to kill MDR cells in vivo. To achieve this objec-
tive, it is important to characterize the nature of the differential
killing of MDR cells and to understand the reasons for its occur-
rence. A fundamental step towards this goal is to establish whether
the underlying mechanism of2DG-induced cell death in MDR cells
is by necrosis or by apoptosis. Because apoptosis is an orderly
process whereby the cell takes an active role in its own destruction
(reviewed by Hale et al, 1996; Umansky, 1996), the occurrence of
preferential cell death by apoptosis may offer additional targets to
modulate and amplify this process, and so lead to useful levels of
selective killing of MDR cells under clinical conditions.
The aim ofthis work, therefore, was to identify and characterize
the underlying mechanism of2DG-induced cell death in a range of
MDR human KB carcinoma cell lines, selected with different
cytotoxic agents, as a step towards this long-term goal of maxi-
mizing the selective killing ofMDR cells.
MATERIALS AND METHODS
Cell culture
The human epidermal carcinoma cell line KB-3-1 and its
multidrug-resistant sublines (KB-Cl, KB-VI and KB-Al) were
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donated by Dr MM Gottesman, or purchased from the American
Tissue Culture Collection. KB-Cl, KB-VI and KB-Al cell lines
were isolated from the KB-3-1 cell line by selection by single
agents: colchicine, vinblastine and doxorubicin respectively
(Akiyama et al, 1985; Shen et al, 1986). The cell lines were
cultured in Dulbecco's modified Eagle medium (DMEM)
containing 25 mm glucose (Gibco), supplemented with 10% fetal
bovine serum (Gibco), 50 U ml-' penicillin and 50 ,ug ml-' strepto-
mycin (Sigma) in 5% carbon dioxide at 37°C. KB-Cl, KB-Vl
and KB-Al cell lines were routinely maintained in 1 ig ml-'
colchicine, vinblastine and doxorubicin respectively. All cell lines
were grown in drug-free medium for 3 days before experiments.
Clonogenic cytotoxicity assay
Cells were seeded in 24-well plates, in the indicated concentra-
tions of 2DG or anti-cancer drug, at a density of 100 (KB-3-1 and
KB-Cl), 200 (KB-VI) or 300 (KB-Al) cells per well. After 8
days' incubation, the cells were fixed and stained with Leishman
stain (2 g 1-1 in methanol) for 40 min, then rinsed in water. The
number of colonies (> 50 cells) was counted and expressed as a
percentage ofthe drug-free controls.
Analysis of GLUT-1 levels
Plasma membrane fractions were isolated as described by
Harrison et al (1990). GLUT-1 levels were determined by Western
blot analysis and quantified by densitometry (Bentley et al, 1996).
Apoptosis induction
Cells were seeded in six-well (for microscopy) or 12-well (for flow
cytometry) plates and cultured in drug-free DMEM for 3 days.
For UV irradiation, DMEM was removed from each well and
the monolayer rinsed with phosphate-buffered saline (PBS). The
cells were irradiated with 200 J m-2 UV in a Stratalinker UV
Crosslinker 1800 (Stratagene). Fresh DMEM was then added and
the cells returned to the incubator for 4 h.
For 2DG treatment, fresh DMEM containing the appropriate
concentrations of 2DG was added to the exponentially growing
cells and culture continued for the indicated time (up to 24 h).
Control cells for both treatments were refed with fresh DMEM.
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Figure 1 Effect of 2-deoxy-D-glucose on the colony-forming ability of KB-3-
1 (D), KB-V1 (-), KB-Cl (O) and KB-Al (*) cells. The number of colonies
(> 50 cells) that formed after 8 days exposure to 2DG was counted and
expressed as a percentage of those in drug-free control wells
Annexin V-FITC/Hoechst 33342/propidium iodide
staining
DMEM, containing floating cells, was removed from each well
and retained. The monolayer was rinsed with PBS, harvested using
trypsin and pooled with the floating cells. The cells were washed
once and resuspended in binding buffer (10 mmHepes/sodium
hydroxide pH 7.4, 150 mm sodium chloride, 5.0 mm potassium
chloride, 1.0 mm magnesium chloride, 1.8 mm calcium chloride)
(Koopman et al, 1994). Annexin V-FITC (BioWhittaker), which
binds to exposed phosphatidylserine (PS), was added to a final
concentration of 2 ,ug ml-' and incubated for 10 min in the dark at
room temperature. Unbound annexin V-FITC was removed by
washing twice in binding buffer and the final cell pellet was resus-
pended in approximately 50 gl of binding buffer. Samples to be
analysed by fluorescence microscopy were additionally stained
with the DNA dye Hoechst 33342 (Ho342) (16 ,ug ml-') for
10 min at 37°C. After staining, all samples were kept on ice in the
dark. To identify cells that had lost plasma membrane integrity,
propidium iodide (PI) (10 jg ml-') was added immediately before
analysis. Labelled cells were analysed by fluorescence microscopy
or flow cytometry.
Table 1 Multidrug resistance phenotype, relative 2-deoxy-D-glucose resistance and relative GLUT-1 levels of
KB carcinoma cell lines selected in different agents
Cell line Selecting Relative resistance to Relative
agent GLUT-1 levels
Col.a Vbl.a Dox.a 2DGa
KB-3-1 - 1 1 1 1 1
KB-V1 Vinblastine 210 837 187 0.38 0.37
KB-Cl Colchicine 262 91 88 0.23 0.48
KB-Al Doxorubicin 82 181 69 0.07 0.63
aRelative resistance was calculated by dividing theD0o value of each MDR cell line by theD0o value of the
parental cell line (KB-3-1), where D10 is the concentration of 2DG which reduced the cloning efficiency of each
cell line to 10% of control values. Col., colchicine; Vbl., vinblastine; Dox., doxorubicin.
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Fluorescence microscopy
Annexin V-FITC/Ho342/PI-labelled cells were examined under a
fluorescence microscope (Zeiss) with excitation at 365 nm (UV
filter) or 450-490 nm (blue filter). The two DNA-binding dyes,
Ho342 and PI, were visible using the UV filter. PI was also visible
using the blue filter, as was annexin V-FITC. Ho342 (blue)
diffuses through plasma membranes and, hence, stains the nuclei
of all cells, regardless of their plasma membrane integrity. In
contrast, PI (red) is excluded by an intact plasma membrane and,
therefore, only stains the nuclei of cells which have lost plasma
membrane integrity, i.e. necrotic cells and those in the late stages
of apoptosis. Annexin V-FITC (green) labels exposed PS on the
outer surface of early and late apoptotic cells and on the inner
surface of necrotic and late apoptotic cells that have lost plasma
membrane integrity. In combination, the three dyes can be used to
identify nuclear morphology, plasma membrane integrity and PS
orientation and are, therefore, able to distinguish between viable
(diffuse nucleus, intact plasma membrane), early apoptotic (exter-
nalized PS, condensed or fragmented nucleus, intact plasma
membrane), late apoptotic (externalized PS, condensed or frag-
mented nucleus, disrupted plasma membrane) or necrotic (swollen
intact nucleus, disrupted plasma membrane) cells.
Cells were scored as viable (blue diffuse nucleus), apoptotic
(early and late combined: condensed and/or fragmented blue or
pink nucleus with green plasma membrane) or necrotic (pink
diffuse nucleus +/- faint green plasma membrane). At least 500
cells per sample were scored and expressed as a percentage of the
total cell population.
Flow cytometry
Annexin V-FITC (Anx)/PI-labelled cells were analysed on a flow
cytometer (Coulter Epics Elite). Excitation was at 488 nm and
emission was detected by FLI (505-545 nm; green; FITC) and
FL2 (560-590 nm; red; PI) sensors. The cytometer was electroni-
cally compensated (23%) to eliminate bleed-through of green
fluorescence into FL2. The percentage of viable (Anx-ve/PI-ve),
early apoptotic (Anx+ve/PI-ve) and late apoptotic or necrotic
(Anx+ve/PI+ve) cells was determined by gating on the three corre-
sponding regions of the annexin V-FITC vs PI histogram. Ten
thousand cells per sample were analysed.
Analysis of poly(ADP-ribose) polymerase (PARP)
cleavage
Control and 50 mm 2DG-treated cells were lysed in samplebuffer [30
mM Tris/HCl pH 7.8, 9% sodium dodecyl sulphate (SDS)] containing
0.1 mm phenylmethylsulphonyl fluoride (PMSF), briefly sonicated to
disrupt the viscous DNA, and the protein concentration was deter-
mined using the Pierce BCA protein kit. Samples containing 30 ig
protein were boiled for 5 min in the presence of 3% 3-mercap-
toethanol and tracker dye (15% w/v glycerol, 0.05% w/v
bromophenol blue in 30 mm Tris/HCl pH 7.8), and run on a 10%
SDS-polyacrylamide gel. Protein was transferred onto nitrocellulose
using the BioRad mini-transblot system. Membranes were stained
with Ponceau S to check for equal loading and transfer, destained in
Tris-buffered saline (TBS) and blocked overnight with 10% (w/v)
dried milk in TBS containing 0.2% Tween 20 (TTBS). The
membranes were then incubated with anti-PARP primary antibody
(Boehringer Mannheim) [1:2000 in 3% (w/v) dried milkinTTBS] for
Figure 2 Nuclear morphology of KB-V1 cells stained with Ho342 (blue),
annexin V-FITC (green) and Pi (pink). KB-V1 cells were untreated (A), UV
irradiated (B) or exposed to 50 mm 2DG for 16 h (C and D). Cells were
examined using the UV (A-C) or blue (D) filters of a fluorescence
microscope. Shown are viable (blue diffuse nuclei), early apoptotic (blue
fragmented nuclei), late apoptotic (pink fragmented nuclei) and necrotic (pink
diffuse nuclei) cells. Annexin V-FITC-positive cells in (D) correspond to the
apoptotic cells from the same field in (C)
2 h, washed three times in TTBS, then incubated with horse radish
peroxidase-conjugated anti-rabbit IgG secondary antibody (1:5000)
for 1 h. Protein was detected by enhanced chemiluminescence
(Amersham ECL kit).
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RESULTS
Effect of 2-deoxy-D-glucose on cell survival
The cytotoxic effect of2DG on three MDR cell lines, KB-C l, KB-
VI and KB-Al (selected with different agents), compared with
their parental non-MDR cell line, KB-3-1, was determined by the
colony formation assay. All three MDR cell lines were preferen-
tially killed by 2DG, compared with the parental KB-3-1 cell line
(Figure 1). TheD1ovalues for KB-3-1, KB-V1, KB-Cl and KB-Al
were 4.60, 1.74, 1.04 and 0.31 mm respectively.
The three MDR cell lines exhibited different levels of sensi-
tivity to 2DG, relative to KB-3-1 cells, that did not correlate with
their levels ofmultidrug resistance (Table 1). Forexample, KB-A
cells show only moderate resistance to conventional agents but
are, by far, the most sensitive ofthe MDR lines to 2DG.
GLUT-1 transporter levels
Previous work has shown that the levels ofthe facilitative glucose
transporter, GLUT-1, are progressively reduced in colchicine-
selected MDR cells expressing increasing levels of multidrug
resistance (Bentley et al, 1996). We, therefore, measured the levels
ofGLUT- I in the three MDR cell lines studied here, each ofwhich
had been selected in the presence of a different drug. KB-A1,
which is the least multidrug resistant ofthe cell lines and the most
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sensitive to 2DG, had arelatively slightreduction in GLUT-I level
(0.63 ofthe control value), whereas KB-V1 and KB-Cl, which are
more multidrug resistant but less sensitive to 2DG, had greater
reduction in GLUT-l levels (0.37 and 0.48 respectively) (Table 1).
Thus, the reduction in the level ofGLUT-I does not correlate with
the sensitivity to 2DG.
Mechanism of cell death associated with 2DG
cytotoxicity
To identify the mechanism of 2DG-induced cell death in MDR
cells, floating and adherent cells (harvested by trypsinization) were
pooled and stained with annexin V-FITC, Ho342 and PI, then
examined by fluorescence microscopy. Microscopic examination
of nuclear morphology and plasma membrane integrity in such
stained cells was the method of choice to establish the basic
features of 2DG-induced cell death in MDR and control cells
because this method will distinguish between necrotic and late
apoptotic cells, unlike non-morphological methods. Examination
using the UV filter showed that untreated cells exhibited non-
condensed nuclei (diffuse blue Ho342), and the majority did not
take up PI (Figure 2A). A significant proportion (quantified below)
of 2DG-treated KB-V1, KB-Cl and KB-Al cells underwent
nuclear condensation and fragmentation, characteristic features of
apoptosis. This is shown for KB-VI in Figure 2C; similar nuclear
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Figure 3 Effects of 2DG exposure (24 h) on KB-3-1 (A), KB-Al, (B), KB-Cl, (C) and KB-V1 (D) cell lines. Control and treated cells were harvested, labelled
with annexin V-FITC, Ho342 and PI, then examined under the fluorescence microscope. The percentages of viable (-), apoptotic (early plus late) (O) and
necrotic (A) cells were calculated from at least 500 cells per sample. Each point represents the mean of triplicate determinations from three separate
experiments ± s.e.m.
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Figure 4 Time course of apoptosis induction in KB-3-1 (A), KB-Al, (B), KB-Cl, (C) and KB-V1 (D) cell lines after continuous exposure to 50 mM 2DG,
determined by flow cytometry. Values are the percentages of Anx-ve/PIl-e (.; viable) and Anx+ve /PIl-e plus Anx+ve/PI+ve [El; apoptotic (+ necrotic)] cells. Each point
represents the mean of values from two independent experiments (each performed in triplicate) ± s.d.
condensation was seen in KB-Cl and KB-Al (not illustrated). The
apoptotic cell population comprised early apoptotic cells (bright
blue fragmented nuclei) and those in the late stages that had lost
plasma membrane integrity and, hence, taken up red PI in addition
to blue Ho342 (pale pink nuclei) (Figure 2C). During the early
stages of apoptosis, cells undergo a redistribution of PS from the
internal to the external leaflet of the plasma membrane, which can
be detectedby green annexin V-FITC labelling (Martin et al, 1995).
When examined under the blue and UV filters in turn, the annexin
V-FITC-positive cells corresponded to those cells with condensed
or fragmented nuclei (Figure 2D compared with 2C), indicating
that PS had been externalized on the outer surface of cells under-
going the characteristic nuclear condensation associated with apop-
tosis. Cells with enlarged and diffuse pink nuclei were classed as
necrotic (single cell in Figure 2A).
The validity of this technique for detecting apoptosis was
confirmed using UV-irradiated KB-V1 cells as positive controls,
because this treatment is a well-documented inducer of apoptosis
(Martin and Cotter, 1991). Treatment of MDR cells with 200 J m-2
UV was shown to produce a similar range of morphological
changes as described above for 2DG-treated cells (Figure 2B). In a
further control, it was shown that trypsinization did not cause the
non-apoptosis-induced exposure ofPS (data not shown) as has been
reported in another adherent cell line (van Engeland et al, 1996).
The dose-response of2DG-induced cell death was quantified by
examining nuclear morphology and PS exposure in exponentially
growing KB-3-1, KB-Al, KB-Cl and KB-Vl cells that had been
incubated in increasing concentrations of2DG for 24 h. 2DG expo-
sure for 24 h did not significantly reduce the proportion of viable
KB-3-1 cells over the entire dose range (0-50 mM) (Figure 3A). In
contrast, in each ofthe three MDR cell lines, the percentage ofcells
with apoptotic features increased greatly with increasing doses of
2DG (Figure 3B-D). In each MDR cell line, a slight increase in the
level of apoptosis could be observed following exposure to 5 mM
2DG, and the level exceeded 60% apoptotic cells following expo-
sure of KB-Cl and KB-Vl cells to 50 mm 2DG. In all four cell
lines, the percentage of necrotic cells did not change appreciably,
even at the highest doses of2DG (Figure 3A-D).
Time course of apoptosis induction by 2DG
The time course of the preferential induction of apoptosis in the
MDR cells was determined by flow cytometry, on the basis of
annexin V-FITC binding (phosphatidylserine exposure) and the
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PARP cleavage in MDR KB cell lines following
exposure to 2DG
The interleukin-converting enzyme-related protease substrate,
PARP, is cleaved from a 113-kDa protein to two fragments of
89 kDa and 24 kDa during many cases of apoptosis (Kaufmann et
al, 1993), and provides further evidence that apoptosis has
occurred. PARP was analysed by Western blotting in total cell
lysates at time points ofup to 24 h exposure to 50 mM 2DG. There
was no evidence ofPARP cleavage in the parental KB-3-1 cells at
any time point (Figure SA). However, the appearance of a 89-kDa
cleavage product and the diminution of the intact 113-kDa mole-
cule was evident in the 2DG-treated KB-Cl cells from 2 h onwards
(Figure SC). PARP cleavage was also apparent in 2DG-treated KB-
Al and KB-V1 cells (Figure SB and D respectively), although this
was not detectable before 8 h. The time course of PARP cleavage
correlated well with that of phosphatidylserine exposure, deter-
mined by flow cytometry (compare Figures 4 and 5).
DISCUSSION
Figure 5 Western blot analysis of PARP integrity in KB-3-1 (A), KB-Al (B),
KB-Cl (C) and KB-V1 (D) cells after exposure to 50 mm 2DG. Treated cells
were harvested at 1, 2, 5, 8, 12 and 24 h exposure times (lanes 2-7). Control
(untreated) cells were harvested at time zero and at 24 h (lanes 1 and 8
respectively). Arrows represent intact PARP (113 kDa) and the 89-kDa
cleavage product
subsequent uptake ofPI (plasma membrane breakdown) that occur
during apoptosis. Because necrotic cells also bind annexin V-FITC
and take up PI, it is not possible to distinguish between necrotic
cells and late apoptotic cells by flow cytometry. However, having
already established that 24 h exposure to 50 mm 2DG does not
induce significant necrosis in these cells, based on nuclear
morphology and plasma membrane integrity (Figure 3A-D), it has
been assumed that an increase in the percentage of dead cells
above background control levels corresponds to cells that have
died via the apoptotic pathway.
To follow the time course of apoptosis induction, the cell lines
were treated with S0 mm 2DG [already shown to induce a signifi-
cant amount of apoptosis in the MDR cell lines at 24 h (Figure
3B-D)] and harvested at various time points up to 24 h. The
percentages of Anx-ve/Pl-ve (viable), Anx+ve/PI-ve (early apoptotic)
and Anx+ve/PI+ve (late apoptotic and necrotic) cells were quantified
by flow cytometry.
In the 2DG-sensitive MDR cell lines, apoptosis was detectable
in a small percentage of cells at the earliest measured time point
(6 h) following exposure to 2DG, and the percentage of apoptotic
cells continued to rise throughout the time course ofdrug exposure
(Figure 4B-D). In contrast, the onset ofthe very slight increase in
apoptosis in the KB-3-1 cell line occurred much later and did not
rise above 10% after correction for background necrotic levels
(Figure 4A).
To gain a better understanding of why different MDR cell lines
have greater sensitivity to 2DG than normal, and to learn how the
preferential killing of such cells may be maximized, the under-
lying mechanism of their death has been investigated. We have
demonstrated by three separate criteria (nuclear morphology,
phosphatidylserine exposure and PARP cleavage) that the prefer-
ential killing of MDR cells by 2DG occurs by apoptosis, over a
wide drug concentration range.
Although 2DG has a preferentially cytotoxic effect on three
MDR cell lines (KB-Cl, KB-Vl and KB-Al) selected with
different agents, compared with their parental cell line (KB-3-1),
there is no direct correlation between the level ofmultidrug resis-
tance and the level of 2DG sensitivity. This contrasts with our
previous finding that the three MDR KB cell lines KB-8-5, KB-8-
5-11 and KB-Cl, which were selected in progressively increasing
concentrations ofthe same agent (colchicine), show progressively
greater 2DG sensitivity with increasing levels of multidrug
resistance (Bentley et al, 1996). The combination of these results
suggests that, although Pgp level may contribute to the extent of
2DG-induced apoptosis in KB cell lines, different selecting agents
select for other changes in MDR cells, distinct from those in Pgp
expression, which influence the level oftheir sensitivity to 2DG.
Kaplan et al (1990) have shown that 2DG exposure leads to a
reduction in ATP levels in MDR and sensitive cells, with a slightly
greater reduction in the former. We have previously shown that a
reduction in levels ofthe facilitative glucose transporter, GLUT-1,
exists in MDR KB cells (Bentley et al, 1996), which may poten-
tiate the reduction in ATP in MDR cells. ATP levels are thought to
be crucial in signalling for apoptosis (Eguchi et al, 1997) and so
depletion of ATP may be a contributory factor in the induction of
the apoptotic pathway by 2DG in our cells. However, the lack of
correlation between the GLUT-1 level and the extent ofsensitivity
to 2DG in different cell lines suggests that other mechanisms may
also be involved.
It is possible to speculate on the nature ofsuch mechanisms. Lavie
et al (1996) have reported that there are higher levels ofglucosylce-
ramide in KB-Vl cells than their sensitive counterparts. Metabolites
ofsuch glycosphingolipids, such as ceramides, are suggested to have
a second messenger function in some signal pathways regulating
apoptosis (Hale etal, 1996; Hannun, 1996). Elevated levels ofprotein
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kinase C (PKC) have also been reported in KB-Al, KB-Cl and KB-
VI cells (Drew et al, 1994). PKC is known to be an important player
in intracellular signalling leading to apoptosis, although its precise
role is yet to be defined (Hale et al, 1996; Leszczynski, 1996).
In conclusion, we propose that a 2DG-stimulated apoptotic
pathway differs in MDR KB cells from that in normal KB cells.
Understanding changes in the pathway involved would provide the
basis for rational suggestions of combinations of treatments to
maximize the killing ofMDR cells. Such studies could be of value
in the clinical situation.
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